• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心包累及癌症。

Pericardial Involvement in Cancer.

机构信息

Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.

Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.

出版信息

Am J Cardiol. 2021 Apr 15;145:151-159. doi: 10.1016/j.amjcard.2020.12.092. Epub 2021 Jan 15.

DOI:10.1016/j.amjcard.2020.12.092
PMID:33460602
Abstract

Despite the monumental advances in the diagnoses and therapeutics of malignancy, several cancer patients have presented with pericardial involvement, including acute pericarditis, constrictive pericarditis, and pericardial effusion. Multiple factors can contribute to acute pericarditis, including direct metastasis to the heart, pericardial hemorrhage, infections due to immunosuppression, and cancer therapies that include chemotherapy, immunotherapy, and radiation. Pericardial effusion, either due to cancer invasion or cancer treatment, is one of the most common incidental findings in cancer patients, which significantly worsens morbidity and mortality. If left untreated, pericardial effusion is known to cause complications such as pericardial tamponade. Constrictive pericarditis can be due to radiation exposure, chemotherapy, or is a sequela of a previous episode of acute pericarditis. In conclusion, early detection, prompt treatment, and understanding of pericardial diseases are necessary to help improve the quality of life of cancer patients, and we aim to summarize the knowledge of pericardial involvement in patients with cancer.

摘要

尽管恶性肿瘤的诊断和治疗取得了重大进展,但仍有一些癌症患者出现了心包受累,包括急性心包炎、缩窄性心包炎和心包积液。多种因素可导致急性心包炎,包括心脏直接转移、心包出血、免疫抑制引起的感染以及包括化疗、免疫疗法和放疗在内的癌症治疗。心包积液无论是由于癌症侵犯还是癌症治疗引起的,都是癌症患者最常见的偶然发现之一,这显著增加了发病率和死亡率。如果不治疗,心包积液已知会引起心包填塞等并发症。缩窄性心包炎可由放射治疗、化疗引起,也可继发于先前的急性心包炎发作。总之,早期发现、及时治疗和了解心包疾病对于提高癌症患者的生活质量是必要的,我们旨在总结癌症患者心包受累的相关知识。

相似文献

1
Pericardial Involvement in Cancer.心包累及癌症。
Am J Cardiol. 2021 Apr 15;145:151-159. doi: 10.1016/j.amjcard.2020.12.092. Epub 2021 Jan 15.
2
Spectrum of pericardial disease: part II.心包疾病谱:第二部分。
Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1159-69. doi: 10.1586/erc.09.79.
3
Pericardial diseases, with a focus on etiology, pathogenesis, pathophysiology, new diagnostic imaging methods, and treatment.心包疾病,重点关注病因、发病机制、病理生理学、新的诊断成像方法及治疗。
Curr Opin Cardiol. 1994 May;9(3):379-88. doi: 10.1097/00001573-199405000-00017.
4
Pericardial disease: a clinical review.心包疾病:临床综述
Expert Rev Cardiovasc Ther. 2016;14(4):525-39. doi: 10.1586/14779072.2016.1134317. Epub 2016 Feb 7.
5
Pericarditis, pericardial effusion, cardiac tamponade, and constriction.心包炎、心包积液、心脏压塞和缩窄性心包炎。
Crit Care Clin. 1989 Jul;5(3):455-76.
6
Medical therapy of pericardial diseases: part II: Noninfectious pericarditis, pericardial effusion and constrictive pericarditis.心包疾病的医学治疗:第二部分:非感染性心包炎、心包积液和缩窄性心包炎。
J Cardiovasc Med (Hagerstown). 2010 Nov;11(11):785-94.
7
An approach to the patient with suspected pericardial disease.疑似心包疾病患者的诊治方法。
S Afr Med J. 2016 Feb;106(2):151-5. doi: 10.7196/samj.2016.v106i2.10328.
8
Pericardial disease in the oncology patient.肿瘤患者的心包疾病
Heart Dis. 2002 Nov-Dec;4(6):387-91. doi: 10.1097/00132580-200211000-00008.
9
Untying the Gordian knot of pericardial diseases: A pragmatic approach.解开心包疾病的难题:一种务实的方法。
Hellenic J Cardiol. 2016 Sep-Oct;57(5):315-322. doi: 10.1016/j.hjc.2016.11.024. Epub 2016 Nov 25.
10
Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes.癌症患者的心包疾病:当代患病率、处理方法和结局。
Heart. 2020 Apr;106(8):569-574. doi: 10.1136/heartjnl-2019-315852. Epub 2020 Jan 24.

引用本文的文献

1
Radiation-induced acute pericarditis after palliative spine radiation in a non-small cell lung cancer patient on osimertinib: a case report.奥希替尼治疗的非小细胞肺癌患者姑息性脊柱放疗后放射性急性心包炎:一例报告
Discov Oncol. 2025 Jul 10;16(1):1299. doi: 10.1007/s12672-025-03176-w.
2
Haemodynamically irrelevant pericardial effusion is associated with increased mortality in maintenance hemodialysis patients with end-stage renal disease.血流动力学无关的心包积液与终末期肾病维持性血液透析患者死亡率增加相关。
BMC Nephrol. 2025 Jul 1;26(1):308. doi: 10.1186/s12882-025-04233-w.
3
The Value of Thin Layer Cytology in Cancer Patients' Pericardial Effusions.
薄层细胞学检查在癌症患者心包积液中的价值
Curr Oncol. 2025 May 26;32(6):306. doi: 10.3390/curroncol32060306.
4
A Comprehensive Review of Cardiac Tumors: Imaging, Pathology, Treatment, and Challenges in the Third Millennium.心脏肿瘤综合综述:第三个千年中的影像学、病理学、治疗及挑战
Diagnostics (Basel). 2025 May 30;15(11):1390. doi: 10.3390/diagnostics15111390.
5
Acute Pericarditis as an Initial Presentation of Neoplastic Disease: A Case Report.急性心包炎作为肿瘤性疾病的首发表现:一例报告
Cureus. 2025 Apr 30;17(4):e83236. doi: 10.7759/cureus.83236. eCollection 2025 Apr.
6
Applications of Artificial Intelligence for the Prediction and Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Oncology Patients.人工智能在肿瘤患者癌症治疗相关心脏功能障碍预测与诊断中的应用
Cancers (Basel). 2025 Feb 11;17(4):605. doi: 10.3390/cancers17040605.
7
A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity.人参皂苷在化疗所致心脏毒性中的心脏保护作用综述
Biomed Eng Online. 2024 Dec 21;23(1):128. doi: 10.1186/s12938-024-01322-z.
8
Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment.癌症患者的心包疾病:诊断与治疗的临床见解
Cancers (Basel). 2024 Oct 12;16(20):3466. doi: 10.3390/cancers16203466.
9
Case Report: Spontaneous acute hemopericardium.病例报告:自发性急性心包积血。
Front Cardiovasc Med. 2024 Oct 1;11:1414519. doi: 10.3389/fcvm.2024.1414519. eCollection 2024.
10
Malignant Pericardial Effusion: A Systematic Review.恶性心包积液:一项系统评价
CJC Open. 2024 May 15;6(8):967-972. doi: 10.1016/j.cjco.2024.05.003. eCollection 2024 Aug.